Astrazeneca (AZN) EBITDA Margin Growth (5y) (2014 - 2026)
Powered by 
Analysis
Astrazeneca (AZN) EBITDA Margin Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Asml Holding | 659.69 Bn | 643.71 Bn | 5.90 Bn |
| 2 | General Electric | 337.12 Bn | 327.78 Bn | 6.95 Bn |
| 3 | Astrazeneca | 247.89 Bn | 242.60 Bn | 12.86 Bn |
| 4 | Citigroup | 236.49 Bn | -2,065.81 Bn | 24.75 Bn |
| 5 | Bhp | 220.99 Bn | 202.45 Bn | - |
| 6 | Rio Tinto | 206.31 Bn | 201.93 Bn | - |
| 7 | Diageo | 192.64 Bn | 190.61 Bn | - |
| 8 | National Grid | 165.59 Bn | 161.82 Bn | - |
| 9 | Unilever | 135.28 Bn | 128.25 Bn | - |
| 10 | Hdfc Bank | 119.43 Bn | 82.28 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 656.00 |
| Mar 31, 2026 | 180.00 |
| Dec 31, 2025 | -199.00 |
| Sep 30, 2025 | 564.00 |
| Jun 30, 2025 | 305.00 |
| Mar 31, 2025 | 786.00 |
| Dec 31, 2024 | -1,098.00 |
| Sep 30, 2024 | 325.00 |
| Jun 30, 2024 | 1,276.00 |
| Mar 31, 2024 | 458.00 |
| Dec 31, 2023 | 276.00 |
| Sep 30, 2023 | 157.00 |
| Jun 30, 2023 | 740.00 |
| Mar 31, 2023 | 1,016.00 |
| Dec 31, 2022 | 1,126.00 |
| Sep 30, 2022 | -1,220.00 |
| Jun 30, 2022 | -1,365.00 |
| Mar 31, 2022 | -1,123.00 |
| Dec 31, 2021 | -2,803.00 |
| Sep 30, 2021 | -3,764.00 |